title: Reinventing phage therapy: are the parts greater than the sum?
abstract: Although whole phage continue to generate interest as an alternative to antibiotics, focus is shifting to the use of purified phage components as antibacterial agents.
authors.affiliation: Laboratory of Bacterial Pathogenesis and Immunology, Rockefeller University, New York, New York 10021, USA. vaf@rockefeller.edu
authors.forename: Vincent A
authors.initials: VA
authors.lastname: Fischetti
authors.forename: Daniel
authors.initials: D
authors.lastname: Nelson
authors.forename: Raymond
authors.initials: R
authors.lastname: Schuch
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000628:therapy*; D001435:Bacteriophages / Q000378:metabolism*; D006801:Humans; D014764:Viral Proteins / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D014764:Viral Proteins